It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The invention relates to tert-Butyl 4-bromo-4-formylpiperidine-1-carboxylate and a series of derivatives, which can be used to treat tumor viruses. This research mainly describe a synthesis route of key intermediate for synthetizing CDK9 inhibitors and Ibrutinib. The synthesis route is mainly consisit of three steps of Boc anhydride protection, oxidation and reduction. This synthesis route provides some valuable references and experimental basis for the synthesis of CDK9 inhibitors and Ibrutinib.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang 330013, China